Quanterix is hosting an upcoming webinar on September 15th featuring Jorge Marques Signes, VP, Laboratory Services, to discuss operational precision in biomarkers for trial enrichment and clinical solutions.
Public source
Publisher name
Public post
Join Jorge Marques Signes, VP, Laboratory Services, Quanterix on September 15th for our upcoming webinar to learn how operational precision #biomarkers can improve trial…
Company
Quanterix
Powering Biomarkers from Discovery to Diagnostics
- Industry
- Biotechnology Research
- Location
- Billerica, US
- Company size
- 501–1,000 employees
About Quanterix
Quanterix is a global leader in precision biomarker science, making biology measurable to deliver earlier insights and support breakthroughs in disease research, diagnostics, and drug development. Its Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. Through the acquisition of Akoya Biosciences, Quanterix Spatial solutions deliver high-plex, quantitative protein analysis in tissue at single-cell resolution. Combined with Accelerator Laboratory services, Quanterix gives researchers the tools and expertise to translate discovery into precision diagnostics. Learn more at www.quanterix.com.
See moreLatest activity
Latest activity from Quanterix
10 signals
Research & Knowledge
Quanterix announced the Simoa® NPTX2 Advantage PLUS Assay enables quantitative measurement of NPTX2 in human samples to support neurodegeneration research.
Presence & Recognition
Quanterix hosted a webinar exploring how researchers can build and optimize high-plex biomarker panels to support emerging hypotheses, incorporate new biomarkers, and generate deeper biological insights.
Products & Services
Quanterix introduced the Simoa APOE Proteotyping Advantage PLUS Kit, which brings APOE4 carrier determination into the same plasma biomarker workflow with no separate genotyping step and no additional sample type.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
LICORbio
LICORbio is hosting a free webinar on Building Robust Potency Assays with In-Cell Western Assay Protein Expression Readouts on September 3, 2026, at 1:00 PM ET with Dr. Kevin Turner from Franklin Biolabs and Dr. Jessica Zinskie from LICORbio.
Presence & Recognition
Bio-Techne
Bio-Techne is hosting a webinar presenting a data-driven strategy for developing multianalyte potency assays that pairs broad biomarker discovery with sensitive, automated protein quantification for CD19 CAR-T and CAR-NK cells.
Presence & Recognition
Franklin Biolabs
Franklin Biolabs is hosting a webinar titled Building Robust Potency Assays with In-Cell Western™ Assay Protein Expression Readouts on September 3, 2026, to learn practical approaches for developing reliable, quantitative potency measurements using protein expression readouts.
Presence & Recognition
Covaris
Covaris is hosting a webinar titled Expanding Access to Personalized Medicine with Cold Chain-Free, Remote Whole Blood Collection on September 9 at 2:00 PM EST.
Presence & Recognition
Thermo Fisher Scientific